The global market for neurostimulation devices is expected to reach USD 8,791.8 million by 2020, according to a new study by Grand View Research, Inc. The presence of high unmet medical needs with limited treatment options in disease segments such as epilepsy, Parkinson’s disease and migraine is one of the highest impact rendering driver of the market. Other key drivers for this market include growing global base of geriatric population, growing use of neuromodulation as an add on therapy and the introduction of technological advancements such as the transdermal neuromodulation technology by Neurowave Medical Technologies and MRI safety enabled devices by Medtronic Inc.
http://www.grandviewresearch.com/industry-analysis/neurostimulation-devices-industry
No comments:
Post a Comment